Refractory Lung Non-Small Cell Carcinoma: Clinical Trials

6 trials for Refractory Lung Non-Small Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 active not recruiting, 1 terminated, 1 withdrawn. 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Active not recruiting 3, Terminated 1
Phase 23Active not recruiting 2, Withdrawn 1

Follow Refractory Lung Non-Small Cell Carcinoma: new trials by email Literature Review of Refractory Lung Non-Small Cell Carcinoma trials Research Report on Refractory Lung Non-Small Cell Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer
Biospecimen Collection, Cemiplimab, Cetuximab Sarotalocan Sodium - Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
Phase 2WithdrawnRoswell Park Cancer Institute2026-08-152026-09-15
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors
Antineoplastic Immune Cell, Atezolizumab, Biospecimen Collection - Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma
Phase 1Active not recruitingUniversity of California, Irvine62022-07-202026-10-06
Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer
Necitumumab, Osimertinib, Quality-of-Life Assessment - Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma
Phase 1 / Phase 2Active not recruitingJonsson Comprehensive Cancer Center302021-01-292026-07-17
Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors
Pembrolizumab, Sonidegib - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8
Phase 1Active not recruitingMayo Clinic362020-02-132026-03-18
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Atezolizumab 1200 MG in 20 ML Injection, Stereotactic Body Radiation Therapy, Varlilumab 3 mg/kg - Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 1TerminatedRutgers, The State University of New Jersey162019-09-112026-02-05
Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer
Atezolizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)532018-11-292026-11-18

Narrower conditions

Carcinoma, Non-Small-Cell Lung (6)  ·  Lung Neoplasms (6)  ·  Carcinoma, Transitional Cell (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Bronchial Neoplasms (6)  ·  Carcinoma, Bronchogenic (6)  ·  Lung Diseases (6)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Respiratory Tract Diseases (6)  ·  Respiratory Tract Neoplasms (6)  ·  Thoracic Neoplasms (6)  ·  Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)

Interventions

atezolizumab (3)  ·  Magnetic Resonance Spectroscopy (2)  ·  Specimen Handling (2)  ·  Biopsy (1)  ·  Cyclophosphamide (1)  ·  Disulfides (1)  ·  Immunoglobulin G (1)  ·  Injections (1)  ·  Ogivri (1)  ·  Ontruzant (1)  ·  PF-05280014 (1)  ·  Photochemotherapy (1)  ·  Radiosurgery (1)  ·  Thoracic Surgery, Video-Assisted (1)  ·  Trastuzumab (1)

Sponsors

Jonsson Comprehensive Cancer Center (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)  ·  Roswell Park Cancer Institute (1)  ·  Rutgers, The State University of New Jersey (1)  ·  University of California, Irvine (1)

Countries

United States (6)

Top investigators

Jonathan W Goldman (1)  ·  Jyoti Malhotra (1)  ·  Miguel Villalona, MD (1)  ·  Mojun Zhu, M.D. (1)  ·  Prantesh Jain (1)  ·  Salma Jabbour (1)  ·  Stephen V Liu (1)

Results publications

PMID 38572955, PMID 39903538

NIH funding

P30CA033572 (1), P30CA072720 (1), R01CA266457 (1), UM1CA186691 (1)